Oct 4., 2018 – Silenseed announced the new website pancan-protact.com for the ongoing Phase II study named PROTACT.  PROTACT, standing for Precise RNAi for Obtaining TArgeted Cancer Therapy, is an acronym that has been selected as for the Phase 2 SLSG12D-P2 study, in order to emphasize the power and hope behind the siG12D-LODER technology – very precise RNAi-based silencing of the well-known yet undruggable KRAS. Recently diagnosed patients with stage III pancreatic cancer can fill-in their details and see if are eligible and can join the trial.